How to manage the menopause following therapy for breast cancer. Is raloxifene a safe alternative?

European Journal of Cancer

Volumn 36, Issue , 2000, Pages 74-76

  Sismondi, P ^a   Biglia, N ^a   Roagna, R ^a   Ponzone, R ^a   Ambroggio, S ^a   Sgro, L ^a   Cozzarella, M ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Breast cancer survivors; Menopause; Raloxifene

Indexed keywords

LOW DENSITY LIPOPROTEIN; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN;

ARTICLE; ATROPHY; BLOOD CLOTTING; BONE METABOLISM; BREAST CANCER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG SAFETY; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; FEMALE; HEART DISEASE; HOT FLUSH; HUMAN; LIPID METABOLISM; MENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPTOMATOLOGY;

BLOOD COAGULATION DISORDERS; BONE DISEASES; BREAST NEOPLASMS; FEMALE; HUMANS; LIPIDS; MENOPAUSE; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATORS; UTERINE DISEASES;

EID: 0033753676     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(00)00235-5     Document Type: Article

References (17)

1. In search of optimal long-term female hormone replacement: The potential of SERMs
2. Encouraging news from the SERM frontier
3. Consensus Statement. Treatment of estrogen deficiency symptoms in women surviving breast cancer
4. Treatment of established postmenopausal osteoporosis with raloxifene: A randomized trial
5. Effects of raloxifene on bone mineral density serum cholesterol concentrations, and uterine endometrium in postmenopausal women
6. Bone histomorphometric results of a 2-year randomized, placebo controlled trial of raloxifene in postmenopausal women
7. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: Results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators
8. Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women
9. Clinical Trial. MORE Investigators
10. A controlled trial of raloxifene (LY139481) HCl: Impact on bone turnover and serum lipid profile in healthy postmenopausal women
11. Lack of effect of raloxifene on coronary artery atherosclerosis of postmenopausal monkeys
12. Chemoprevention of mammary carcinogenesis in the rat: Combined use of raloxifene and 9-cis-retinoic acid
13. The effect of raloxifene on risk of breast cancer in postmenopausal women: Results from the MORE randomized trial
14. Raloxifene (LY 139481 HCl): Bone, lipid and uterine effects in the ovariectomized rat model
15. Life after breast cancer: Understanding women's health related quality of life and sexual functioning
16. Megestrol acetate for the prevention of hot flushes
17. Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flushes in cancer survivors